Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Working paper
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 1637 - 1645
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Journal article
Morris EJA. et al, (2021), The lancet. Gastroenterology & hepatology, 6, 199 - 208
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 605 - 612
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2021), The New England journal of medicine, 384, 693 - 704
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
Horby P. et al, (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2020), The New England journal of medicine, 383, 2030 - 2040
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article
Zhu P. et al, (2020), Journal of the American Society of Nephrology : JASN
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2020), Lancet (London, England)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
Journal article
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA, 324, 1330 - 1341
Lopinavir-ritonavir in Hospitalised Patients with COVID-19 – a randomised, controlled, open-label, platform trial
Journal article
LINSELL L. et al, (2020), The Lancet
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article
HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
Journal article
LANDRAY M., (2020), JAMA: Journal of the American Medical Association
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Journal article
Hopewell JC. et al, (2020), European heart journal, 41, 3336 - 3342
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
Journal article
Mafham MM. et al, (2020), Lancet (London, England), 396, 381 - 389
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Journal article
Herrington WG. et al, (2020), Clinical kidney journal, 13